CDSCO targets 18-month rollout for end-to-end digital drug regulation platform
India’s drug regulator plans a platform spanning manufacturing, approvals, distribution and post-market surveillance. CDSCO is also piloting AI tools, QR-authenticated GMP/COPP certificates and faster pathways for innovative therapies.
CDSCO will launch a digital platform covering India’s drug regulatory chain, including manufacturing, approvals, distribution and post-market surveillance, within 18 months. It is also piloting AI, QR-authenticated GMP/COPP certificates and faster pathways for innovative therapies.
Why this matters
CDSCO’s platform plan follows its enforcement push against high-risk drug facilities inspected since late 2022, pairing stricter oversight with digital systems for approvals, certificates and surveillance.
Retail-company signals are accelerating, up 253720% QoQ.